Company Overview

Update
Founded:
2004
Headquarters:
Kalamazoo, MI
Funding:
$77.50M
Categories:
Biotechnology

ProNAi Therapeutics is a biotech company leveraging its proprietary nucleic acid-based interfering technology, DNAi®, for cancer patients.

Description

Update

ProNAi Therapeutics, Inc. is a DNA Interference (DNAi®)-based biopharmaceutical company that is leveraging its novel and proprietary nucleic acid-based interfering technology, DNAi®, to advance a next generation of therapies for patients with cancer and other complex genetic diseases.

Current Team (1)

Update

Funding Rounds (4) - $77.50M

Update

Investors (9)

Update

Offices/Locations (1)

Update
  • Office

    4717 Campus Drive

    Suite 1100

    Kalamazoo, MI 49008

    USA